From Globe Newswire: 2024-11-12 12:11:00

Kronos Advanced Technologies has formed a new subsidiary, Atomiq Inc., focusing on nuclear battery technology and sustainable energy solutions. Kronos filed a provisional patent for atomic battery innovations, positioning both companies at the forefront of nuclear battery innovation. The global nuclear battery market is projected to grow significantly, with a Compound Annual Growth Rate (CAGR) of 10.5% from 2022 to 2030. Atomiq is strategically targeting high-demand sectors like aerospace, defense, and medical technology with its cutting-edge nuclear battery technologies. Radioisotope Thermoelectric Generators (RTGs) and Betavoltaic Batteries are key devices in the small nuclear battery industry, offering long-lasting, maintenance-free power solutions for various applications. Market projections estimate the nuclear battery market to reach $87.2 billion by 2026, driven by increasing demand for reliable and long-lasting power sources. The small nuclear battery industry is experiencing rapid growth due to the demand for long-lasting power sources in various sectors. Technological advancements and environmental considerations are also fueling the growth of nuclear batteries as they offer a low-carbon alternative to traditional power sources. Small nuclear batteries are utilized in space missions, medical devices, and remote monitoring applications, providing reliable power in challenging environments. Atomiq aims to develop nuclear batteries that offer an extended lifespan and contribute to achieving carbon neutrality across various sectors. With the formation of Atomiq Inc., Kronos Advanced Technologies is positioning itself as a leader in sustainable energy solutions and a catalyst for innovation in atomic batteries. Atomiq’s vision aligns with providing reliable, sustainable energy for critical, high-demand applications. Kronos Advanced Technologies has a history of innovation, focusing on developing disruptive technology solutions in advanced energy and environmental quality. The company’s patented High Voltage Field air disinfection technology has been recognized by the U.S. Food and Drug Administration (FDA), granting 510(k) clearance for its Model 5 Air Purifier as a Class II Medical Device. This clearance validates Kronos’ technology in eliminating harmful airborne particles and improving Indoor Air Quality (IAQ) in various settings. Kronos can now deploy its medical-grade air purification technology in hospitals, healthcare facilities, schools, and more, enhancing air quality and safety. The company’s commitment to customer satisfaction and innovation remains strong as it continues to develop and market air purifiers and consumer products. Kronos Advanced Technologies is dedicated to enhancing the health and well-being of individuals worldwide, offering innovative products to address evolving industry needs. The company’s exclusive distribution of air purifiers based on its patented technology underscores its commitment to providing high-quality, efficient products. With a focus on sustainability and efficiency, Kronos aims to capture emerging opportunities in the nuclear battery sector and other high-tech industries.



Read more at Globe Newswire: Kronos Advanced Technologies Forms New Subsidiary Atomiq,